Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age
Richard Tanner, Neasa Starr, Grace Chan, Eimear Dempsey, Emma Heffernan, Ellen Newman, James P. O’Neill, Margaret M. Hannan, Breda Lynch, Emer Joyce
Topics & Concepts
VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakBetacoronavirusMedicineImmunologyBiologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchVirus-based gene therapy researchImmunotherapy and Immune Responses